Strata Critical Medical annual free cash flow
2019
2021
2022
2023
2024
2025
Strata Critical Medical Free Cash Flow (FCF) History (SRTA)
Strata Critical Medical reported −$58.5M in free cash flow for fiscal 2025, a decrease of $25.1M from the previous fiscal year, with a free cash flow margin of −29.68%.
View full Strata Critical Medical company overviewStrata Critical Medical free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −$58.5M | −$25.1M | — | −29.68% |
| 2024 | 2024-12-31 | −$33.4M | $1.1M | — | −22.74% |
| 2023 | 2023-12-31 | −$34.5M | $3.4M | — | −15.30% |
| 2022 | 2022-12-31 | −$37.9M | −$21.9M | — | −25.91% |
| 2021 | 2021-09-30 | −$15.9M | −$5.0M | — | −31.49% |
| 2019 | 2019-09-30 | −$10.9M | — | — | −34.96% |
Strata Critical Medical quarterly free cash flow
Q1.21
Q2.21
Q4.21
Q2.22
Q3.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.2M | $8.5M | — | +4.41% |
| Q1 2026 | 2026-03-31 | −$1.3M | $1.6M | — | −1.92% |
| Q4 2025 | 2025-12-31 | −$10.2M | −$3.8M | — | −15.21% |
| Q3 2025 | 2025-09-30 | −$40.2M | −$37.2M | — | −81.53% |
| Q2 2025 | 2025-06-30 | −$5.3M | $2.4M | — | −11.75% |
| Q1 2025 | 2025-03-31 | −$2.9M | $13.5M | — | −7.96% |
| Q4 2024 | 2024-12-31 | −$6.3M | $3.0M | — | — |
| Q3 2024 | 2024-09-30 | −$3.0M | −$4.3M | — | −8.19% |
| Q2 2024 | 2024-06-30 | −$7.7M | $1.2M | — | −11.38% |
| Q1 2024 | 2024-03-31 | −$16.4M | $1.1M | — | −31.77% |
| Q4 2023 | 2023-12-31 | −$9.3M | −$229,000 | — | −19.68% |
| Q3 2023 | 2023-09-30 | $1.3M | $7.8M | — | +1.86% |
| Q2 2023 | 2023-06-30 | −$8.9M | $2.9M | — | −14.66% |
| Q1 2023 | 2023-03-31 | −$17.5M | −$7.0M | — | −38.66% |
| Q4 2022 | 2022-12-31 | −$9.1M | −$3.3M | — | −23.90% |
| Q3 2022 · Sep 30 | 2022-09-30 | −$6.4M | $2.9M | — | −14.09% |
| Q3 2022 · Jun 30 | 2022-06-30 | −$11.8M | −$11.1M | — | −33.11% |
| Q2 2022 | 2022-03-31 | −$10.5M | — | — | −39.44% |
| Q4 2021 | 2021-09-30 | −$5.9M | — | — | −28.83% |
| Q2 2021 | 2021-06-30 | −$9.4M | — | — | −72.29% |
| Q1 2021 | 2021-03-31 | −$658,000 | — | — | −7.10% |
Strata Critical Medical free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$10.9M to −$58.5M, a net decrease of $47.6M. Strata Critical Medical's latest reported quarter, Q2 2026, generated $3.2M in free cash flow, an increase of $8.5M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Strata Critical Medical filings at SEC.gov ↗